Sanofi annual gross profit
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Sanofi Gross Profit Growth & History (SAN)
Sanofi's gross profit was €33.67B for fiscal 2025.
View full Sanofi company overviewSanofi annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €33.67B | €2.59B | +8.32% |
| 2024 | 2024-12-31 | €31.08B | €2.09B | +7.21% |
| 2023 | 2023-12-31 | €28.99B | €311.0M | +1.08% |
| 2022 | 2022-12-31 | €28.68B | €1.76B | +6.53% |
| 2021 | 2021-12-31 | €26.92B | €1.71B | +6.78% |
| 2020 | 2020-12-31 | €25.21B | −€442.0M | −1.72% |
| 2019 | 2019-12-31 | €25.65B | €1.41B | +5.82% |
| 2018 | 2018-12-31 | €24.24B | −€366.0M | −1.49% |
| 2017 | 2017-12-31 | €24.61B | €613.0M | +2.55% |
| 2016 | 2016-12-31 | €24.00B | €53.0M | +0.22% |
| 2015 | 2015-12-31 | €23.94B | — | — |
Sanofi gross profit trends
Over the last five fiscal years, Sanofi's gross profit increased from €25.21B to €33.67B, a change of €8.46B.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sanofi source filings ↗Community posts
Sanofi raises annual outlook as Dupixent drives double-digit sales growth
Sanofi ($SAN-EURONEXT) increased its 2026 outlook to low-teens sales growth and mid-teens growth in business earnings per share, both at constant exchange rates. Third-quarter 2026 sales reached €14.44 billion, increasing 14.3% on that basi ...
